CHRSCoherus Oncology, Inc.vs its industry peers
A metric-by-metric comparison of Coherus Oncology, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHRS본 종목 | $124M#6 | — | 2.0x#7 | 3.0x#3 | 59.8%#2 | 489.4%#1 | -429.5%#4 | 276.2%#2 | -351.2%#3 | — | -49.3%#1 | — |
| DTIL | $194M#1 | 21.7x#2 | 3.7x#9 | 5.7x#4 | -50.1%#4 | -738.0%#13 | -152.2%#1 | -88.3%#9 | — | — | — | — |
| LIMN | $169M#2 | — | 563.0x#11 | — | — | -187.8%#12 | — | -3395.2%#11 | -170.3%#2 | — | -96.2%#9 | — |
| STRO | $157M#3 | — | — | 1.5x#1 | 65.2%#1 | 15.9%#4 | -154.5%#2 | — | — | — | — | — |
| TARA | $144M#4 | — | 0.9x#5 | 48.7x#6 | — | -28.7%#7 | -2189.6%#6 | -35.6%#3 | — | — | -52.4%#2 | — |
| CMPX | $138M#5 | — | 0.8x#4 | — | -100.0%#5 | -34.7%#8 | — | -40.0%#4 | — | — | -79.5%#6 | — |
| HUMA | $122M#7 | — | 3.9x#10 | 59.7x#7 | — | 72.5%#2 | -5306.0%#8 | -130.6%#10 | — | — | -72.4%#5 | — |
| ARMP | $114M#8 | — | — | — | — | -818.8%#14 | — | — | — | — | — | 0.1%#1 |
| VYGR | $113M#9 | — | 0.7x#3 | 2.8x#2 | -49.5%#3 | -84.2%#10 | -326.6%#3 | -77.6%#8 | — | — | -59.9%#3 | — |
| OTLK | $112M#10 | — | — | 79.3x#8 | — | 17.2%#3 | -4744.3%#7 | — | -12.8%#1 | — | -64.7%#4 | — |
| AVXL | $112M#11 | — | 1.0x#6 | — | — | -7.8%#6 | — | -41.2%#5 | — | — | -84.4%#8 | — |
| LENZ | $110M#12 | — | 0.6x#2 | 5.8x#5 | — | -65.0%#9 | -477.5%#5 | -42.8%#6 | — | — | — | — |
| ENGN | $109M#13 | 0.6x#1 | 0.5x#1 | — | — | -112.7%#11 | — | -50.9%#7 | — | — | — | — |
| NMRA | $108M#14 | — | 2.4x#8 | — | — | -2.8%#5 | — | 532.2%#1 | -594.0%#4 | — | -80.8%#7 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice